ABIDJAN, 13 November 2018 – A joint framework of the Economic Community of West African States (ECOWAS) aimed at upgrading the region’s pharmaceutical industry in line with international Good Manufacturing Practices (GMP) standards was successfully validated today by the Community’s Member States during a stakeholders meeting organized in Abidjan, Côte d’Ivoire. The framework was developed by the United Nations Industrial Development Organization (UNIDO) with support from the West African Health Organization (WAHO) as part of a collaboration which began in January 2017.
The regional workshop held under the presidency of the Ivorian Minister of Health and Public Hygiene was attended by over 60 delegates from across West Africa, including senior representatives from national medicines regulators of all ECOWAS Member States, pharmaceutical manufacturers from the region and development partners such as the African Development Bank (AfDB), the Agence Française de Développement (AFD), the Joint United Nations Programme on HIV/AIDS (UNAIDS), United States Pharmacopeia (USP) and the World Health Organization (WHO). The participants engaged in two days of rich discussions while reviewing the deliverables of the project implemented as part of the ECOWAS Regional Pharmaceutical Plan (ERPP).
Chaired by the President of the West African Pharmaceutical Manufacturers Association, Dr. Akpa, the meeting also highlighted strategic and technical follow-on initiatives that need to be conducted for the pharmaceutical industry in West Africa to reach its potential for improving access to quality essential medicines while directly contributing to the economic growth of the ECOWAS region.
For more information, please contact:
Business Plan Coordinator
UNIDO Investment Promotion Division